CJEU clarifies rules on parallel pharma imports

19-02-2015

CJEU clarifies rules on parallel pharma imports

Jiri Flogel / Shutterstock.com

The Court of Justice of the European Union (CJEU) has clarified when pharmaceutical patent owners may rely on the Specific Mechanism to prevent parallel imports of their products.


CJEU, Merck, Sigma, parallel imports, specific mechanism, patent

LSIPR